Related Companies
|
[]
|
||||||||
Related Funds
|
[]
|
||||||||
|
|||||||||
English
|
|||||||||
oda_NoncurrentFinancialAssetSaleAbstract|
|
|
||||||||
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_AnnouncementContentSection|
|
|
||||||||
oda_BoardDecisionDateForSale|
|
|
28/07/2025
|
|||||||
oda_WereMajorityOfIndependentBoardMembersApprovedTheBoardDecisionForSale|
|
|
Yes
|
|||||||
oda_TitleOfNoncurrentFinancialAssetSold|
|
|
S&Mohr İplik Fabrikaları A.Ş.
|
|||||||
oda_FieldOfActivityNoncurrentFinancialAssetSold|
|
|
Production of all types of thread and yarn, including surgical thread and needles of all types and sizes
|
|||||||
oda_CapitalOfNoncurrentFinancialAssetSold|
|
|
42,109,340 TL
|
|||||||
oda_DateOnWhichRheTransactionWasWillBeCompleted|
|
|
28.07.2025
|
|||||||
oda_SalesConditions|
|
|
Peşin (Cash)
|
|||||||
oda_NominalValueOfSharesSold|
|
|
6,316,401 TL
|
|||||||
oda_SalesPricePerShare|
|
|
4.01 TL
|
|||||||
oda_TotalSalesValue|
|
|
25,315,048.35 TL
|
|||||||
oda_RatioOfSharesSoldToCapitalOfNoncurrentFinancialAsset|
|
|
15
|
|||||||
oda_TotalRatioOfSharesOwnedInCapitalOfNoncurrentFinancialAssetAfterSalesTransaction|
|
|
34
|
|||||||
oda_TotalVotingRightRatioOwnedInNoncurrentFinancialAssetAfterSalesTransaction|
|
|
34
|
|||||||
oda_RatioOfNoncurrentFinancialAssetSoldToTotalAssetsInLatestDisclosedFinancialStatementsOfCompany|
|
|
0.84
|
|||||||
oda_RatioOfTransactionValueToSalesInLatestAnnualFinancialStatementsOfCompany|
|
|
1.21
|
|||||||
oda_EffectsOnCompanyOperations|
|
|
None.
|
|||||||
oda_ProfitLossArisedAfterTransaction|
|
|
-
|
|||||||
oda_HowWillSalesProfitBeUsedIfExists|
|
|
-
|
|||||||
oda_BoardDecisionDateForUseOfSalesProfitIfExists|
|
|
-
|
|||||||
oda_TitleNameSurnameOfCounterPartyBought|
|
|
Internacional Farmaceutice S.A de C.V.
|
|||||||
oda_IsCounterPartyARelatedPartyAccordingToCMBRegulations|
|
|
Hayır (No)
|
|||||||
oda_RelationWithCounterPartyIfAny|http://www.xbrl.org/2003/role/verboseLabel
|
|
Partner of S&Mohr America S.A de C.V. and S&Mohr İplik Fabrikaları A.Ş., subsidiaries of our company
|
|||||||
oda_AgreementSigningDateIfExists|
|
|
28/07/2025
|
|||||||
oda_ValueDeterminationMethodOfNoncurrentFinancialAsset|
|
|
Negotiation Procedure
|
|||||||
oda_DidValuationReportBePrepared|
|
|
Düzenlenmedi (Not Prepared)
|
|||||||
oda_ReasonForNotPreparingValuationReportIfItWasNotPrepared|
|
|
Because it is not required by law.
|
|||||||
oda_DateAndNumberOfValuationReport|
|
|
-
|
|||||||
oda_TitleOfValuationCompanyPreparedReport|
|
|
-
|
|||||||
oda_ValueDeterminedInValuationReportIfExists|
|
|
-
|
|||||||
oda_ReasonsIfTransactionWasntWillNotBePerformedInAccordanceWithValuationReport|
|
|
-
|
|||||||
oda_ExplanationSection|
|
|
||||||||
oda_ExplanationTextBlock|
|
At the meeting of our Company's Board of Directors held on July 28, 2025;
It was decided to sell 6,316,401 shares of our affiliate S&Mohr İplik Fabrikaları A.Ş., located at İbni Melek Osb Mahallesi Tosbi Yol 4 Sokak N33-35/1 Tire -İzmir, has been decided to be sold to Internacional Farmaceutica S.A de C.V. for a total of 625,500 USD.
This decision was made in line with the Company's strategic objectives and does not currently affect cash flow or operational activities.
It is respectfully announced to the public.
The English translation of this statement is attached herewith and in case of any discrepancy in the texts of the statement, the Turkish version will be taken as the basis.
|